Clinical Trials
First ever study to apply therapeutic approach of global...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard (Lyon), the major...
Clinical Trials
FDA approves linagliptin tablets for the treatment of type...
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along...
Clinical Trials
Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement...
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the...
Clinical Trials
Biogen Idec Receives Positive Opinion from the CHMP and...
Biogen Idec announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval...
Clinical Trials
Boehringer Ingelheim’s lead hepatitis C compound moves into phase...
Boehringer Ingelheim announced the study outline for the pivotal Phase III clinical trials designed to evaluate BI 201335, its investigational once-daily oral protease inhibitor, in...
Clinical Trials
Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in...
Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the initiation of a Phase IIa clinical trial to evaluate dipraglurant in patients with Parkinson’s disease...
Clinical Trials
Adocia reports positive phase I clinical results on HinsBet(R),...
Adocia, a privately-held biotechnology company specialized in regenerative medicine and in the treatment of chronic diseases, announced today positive results from its phase I clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.